Structured evidence table for Alpha Gpc Cognitive Performance Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Alpha Gpc Cognitive Performance Meta-Analysis | Next, we integrate evidence on the ergogenic effects of various dietary interventions with existing knowledge on the perception of effort. | 4 | Strasser B (2026) | Dietary interventions interact with the perception of effort and enhance endurance performance: a brief narrative review. |
| Alpha Gpc Cognitive Performance Meta-Analysis | Beta-alanine, caffeine or carbohydrate mouth rinsing are examples of evidence-based ergogenic aids. | 4 | Strasser B (2026) | Dietary interventions interact with the perception of effort and enhance endurance performance: a brief narrative review. |
| Alpha Gpc Cognitive Performance Meta-Analysis | Conclusion While current evidence supports a key role for dietary interventions on endurance performance by influencing individuals' perceived effort, more research is needed to determine the optimal doses and precise formulations for different sports, in order to employ a personalized strategy. | 4 | Strasser B (2026) | Dietary interventions interact with the perception of effort and enhance endurance performance: a brief narrative review. |
| Alpha Gpc Cognitive Performance Meta-Analysis | Background Exercise tolerance is a pivotal factor in determining athletic competitive success, as well as mobility and quality of life in elderly individuals and those afflicted by chronic ailments. | 4 | Strasser B (2026) | Dietary interventions interact with the perception of effort and enhance endurance performance: a brief narrative review. |
| Alpha Gpc Cognitive Performance Meta-Analysis | This narrative review summarizes current preclinical and clinical evidence regarding the mechanistic and clinical relevance of L-α-GPC in neurodegenerative disorders associated with cognitive impairment. | 4 | Putri VA (2026) | L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. |
| Alpha Gpc Cognitive Performance Meta-Analysis | In animal models, L-α-GPC has been associated with improved cognitive performance, reduced neuroinflammation, and attenuation of amyloid-β and tau-related pathological features. | 4 | Putri VA (2026) | L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. |
| Alpha Gpc Cognitive Performance Meta-Analysis | However, the interpretation of these findings should be cautious because the available evidence remains heterogeneous, with notable variability in study design, dosage regimens, treatment duration, and outcome measures. | 4 | Putri VA (2026) | L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. |
| Alpha Gpc Cognitive Performance Meta-Analysis | Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and vascular dementia are characterized by progressive neuronal loss, synaptic dysfunction, and cognitive decline. | 4 | Putri VA (2026) | L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. |
Source documents